Medicine & Health

Lindsay Stark, a professor at the Brown School, has received a one-year $435,000 grant from UNICEF for a project titled “Intervention Review and Implementation Research to Address Gender-based Violence in Emergencies.”

The U.S. Department of Health and Human Services has awarded researchers Ellen Fitzsimmons-Craft and Denise Wilfley a grant to help improve outcomes for eating disorders in adolescent girls.

Research from the lab of Brian Carpenter, in Arts & Sciences, suggests older adults understood that sometimes-unflattering COVID-19 messaging came from a place of caring and compassion.

Research from the lab of Fangqiong Ling at the McKelvey School of Engineering finds SARS-CoV-2 material in wastewater reflects illnesses in communities. It also helps establish guidance for future studies.

Washington University has licensed the rights to develop, manufacture and commercialize its proprietary COVID-19 nasal vaccine in the United States, Europe and Japan to Ocugen Inc., a U.S.-based biotechnology company.

The White House has sounded the alarm about vulnerabilities in the pharmaceutical supply chain. But new research from the Center for Analytics and Business Insights at Olin Business School found that the U.S. actually has the capacity to make the nation’s most essential and critical drugs — yet it’s mostly sitting idle.

People who lived in neighborhoods with ready access to civic and social organizations displayed higher cognitive scores than those who lived in neighborhoods with no immediate access to such organizations, finds a new study by researchers at Washington University in St. Louis and University of Michigan.

Research from a multi-institutional team, including Randall Martin at the McKelvey School of Engineering, estimated sugarcane fires in South Florida produce harmful emissions in quantities on par with vehicles — and play a role in the region’s mortality rates.

Fred Ssewamala, the William E. Gordon Distinguished Professor at the Brown School, received a five-year $3.2 million grant from the National Institutes of Health to lead a study on intervention strategies for HIV treatments among Ugandan youth. The study could advance intervention science for HIV care globally.

The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.